Platysma Prominence Clinical Trial
Official title:
Phase 3, Multicenter Open-label Extension Study to Evaluate the Safety of BOTOX (Botulinum Toxin Type A) Purified Neurotoxin Complex for the Treatment of Platysma Prominence
This is a Phase 3, open-label study to evaluate the safety of BOTOX Injection in Adult Participants with Platysma Prominence
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05773053 -
A Study of NT 201 Doses in the Treatment of Platysma Prominence
|
Phase 2 | |
Completed |
NCT04949399 -
A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma Prominence
|
Phase 3 | |
Completed |
NCT04994535 -
A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence
|
Phase 3 | |
Completed |
NCT03915067 -
BOTOX® for the Treatment of Platysma Prominence
|
Phase 2 |